Global AI hearing aid market to reach US$ 7.51 billion by 2034: Fact.MR report

Rapid growth in the AI hearing aid sector is fueled by enhanced connectivity, smartphone integration, and machine learning algorithms

0
165
New Delhi: The global AI hearing aid market is projected to see significant growth, reaching a valuation of US$ 7.51 billion by 2034, according to a new study by Fact.MR. The report predicts that the market will hit US$ 3.12 billion by 2024, with a compound annual growth rate (CAGR) of 9.2% over the next decade. 
This growth is attributed to advancements in artificial intelligence (AI), which enhances hearing aids by improving speech recognition and comprehension, allowing users to adapt to various listening environments and offering a more personalized experience.
A key driver of market expansion is the focus on user convenience. Leading companies are enhancing integration with smartphones and other smart devices, which allows users to adjust their hearing aids remotely, stream audio directly from their phones, and monitor health metrics like hearing aid usage and overall hearing health. This level of connectivity is transforming the user experience by offering superior sound quality and ease of use.
Regionally, North America leads the market due to its strong healthcare infrastructure and rapid adoption of new technology. It is set to account for a 2% share of the global market by 2034. Western Europe is also expected to maintain a significant market share during the forecast period, driven by stringent healthcare regulations and high-quality standards in the manufacturing of medical devices. 
Meanwhile, the United States is estimated to reach a market size of US$ 1.16 billion by 2024, while South Korea is expected to grow from US$ 88.9 million in 2024 to US$ 236.5 million by 2034. India is another emerging market, with demand for AI hearing aids forecasted to grow at a 2% CAGR through 2034.
The study also highlights the popularity of behind-the-ear AI hearing aids, which are expected to generate US$ 2.98 billion in sales by 2034. In terms of technology, machine learning algorithms (MLA) are becoming increasingly prevalent, offering adaptive and personalized experiences for users by analyzing auditory data, separating speech from background noise, and automatically adjusting the hearing aid’s settings for optimal sound quality. The MLA segment is anticipated to hold a 3% market share by 2024.
The market is being driven by innovation from key players, including Sonova, GN Hearing A/S, Starkey Laboratories, Inc., and Zhejiang Nurotron Biotechnology Co., Ltd. These companies are continuously launching products that are more comfortable, lightweight, and easy to integrate with smartphones, while also offering improved sound quality. 
Starkey, for instance, introduced a new line of customized hearing aids called the Signature Series in February 2024 and updated its Genesis AI hearing aid with enhanced sound features. Similarly, iFlytek released a new behind-the-ear hearing aid in China in April 2024, featuring AI-powered scene detection and an industry-leading 65dB audio gain.
The use of machine learning algorithms in AI hearing aids enables these devices to improve over time, offering users a personalized experience that adjusts to their unique hearing needs and changing environments. These algorithms analyze large amounts of auditory data, detect patterns, and help the hearing aid automatically fine-tune its settings. This technology ensures that users receive the best possible hearing assistance under diverse conditions, significantly enhancing the functionality and performance of AI hearing aids.
“To improve their profits and market position, key manufacturing are launching AI hearing aid products that are more comfortable, lightweight, easy to use and integrate with smartphones, and also have better sound quality, and others,” says a Fact.MR analyst
Fact.MR’s research provides a comprehensive analysis of the AI hearing aid market, including historical data from 2019 to 2023 and forecast statistics from 2024 to 2034. The study offers insights based on product type, indication, age group, diagnosis, technology, and end user, while examining trends across major global regions such as North America, Western Europe, Eastern Europe, East Asia, Latin America, South Asia & Pacific, and the Middle East & Africa (MEA).